StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alnylam Pharma. (ALNY) PT Lowered; RBC Capital: 'Tough Update But Stock Reaction Looks Overdone'
July 31, 2026 8:09 AM
(Updated - July 31, 2026 10:04 AM EDT)
RBC Capital analyst Luca Issi lowered the price target on Alnylam ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Raymond James Upgrades Alnylam Pharmaceuticals (ALNY) to Strong Buy
August 3, 2026 7:20 AM